Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Multiple Ascending Dose (MAD) Study of EC5026 in Healthy Volunteers

NCT06089837 is registered in ClinicalTrials.gov with EicOsis Human Health Inc. as lead sponsor.

NCT NCT06089837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06089837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Multiple Ascending Dose (MAD) Study of EC5026 in Healthy Volunteers
Lead sponsor
EicOsis Human Health Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 28, 2023
Completion date
May 12, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects